Chapter 143 Press Conference (Part 2)
"The second new drug is the anti-drug special drug No. 4 - Langfu Anning..."
Langfu Anning? Xie Bin's eyes widened immediately. Langfu? Being proficient in English, he immediately had a lot of thoughts about this term. Could this English transliteration be...?
Tian Hemeng pointed to the big screen on the stage and said, "This is the treatment range, usage, treatment effect, and drug contraindications of the Langfu Anning special medicine..."
At this point, everyone was staring at the big screen intently.
"They have actually developed a targeted virus antibiotic." Martin from Roche was very surprised, and at the same time, he was overwhelmed with greed.
There are many European pharmaceutical company representatives who share the same idea as him.
Obviously they have seen the huge benefits.
The representatives of several pharmaceutical companies from China, including Sinopharm Group, Yangtze River Pharmaceutical, Yangcheng Pharmaceutical, etc., also showed uncertain expressions at this time.
The representatives of these pharmaceutical companies did not actually come specifically to participate in the press conference, but they have a lot of business cooperation with Qingye Medical, so they set up offices in Bina.
Participating in the press conference is just to give face and to show support.
But they didn't expect Qingye Medical to make another big move. The head of Sinopharm's office reacted the fastest. He directly asked his assistant to send an email to the headquarters.
The scene quickly became chaotic, with representatives from many companies trying to contact the headquarters to report on Aoba Medical's new drugs.
In particular, Tian Hemeng projected many patients' medication reports on the big screen. Although specific drugs cannot allow patients to obtain antibodies, they can at least save lives.
Xie Bin, who had already obtained special authorization from the board of directors, stood up very decisively and walked towards Tian Hemeng.
Harry from Sapiens also took the same action.
Before Tian Hemeng stepped off the stage, he was stopped by Xie Bin and Harry who were coming towards him.
Xie Bin couldn't wait to ask: "Mr. Tian, is there any discount on the special medicine? If the price is right, our company is willing to purchase 100,000 boxes."
He was very clear about the scale of drug production of Qingye Medical, and estimated that the production of Anti-Drug No. 4 - Langfu Anning would not exceed hundreds of thousands of boxes per month. If he didn't act quickly, the opportunity would be lost.
"Our company also needs 100,000 boxes. How about 4,500 gold dollars per box?" Harry started to bargain with a smile.
But Tian Hemeng had no intention of giving in: "5,000 is the lowest price. After all, our company needs to invest a lot in research and development."
Harry paused for a moment, as if he was worried that Xie Bin would steal his business, so he gritted his teeth and agreed: "Then it's 5,000 gold yuan per box. I hope these 100,000 boxes can be supplied first."
Damn it! Before Xie Bin could even say anything, Harry directly gave 100,000 boxes.
He was worried that other companies would come, so he didn't care about the discount and said quickly, "Boss Tian, it's 5,000 gold yuan per box. Please arrange 100,000 boxes for our company as soon as possible."
"Haha, no problem." Tian Hemeng agreed with a smile on her face. She has been engaged in pharmaceutical sales for so many years, but this is the first time she has encountered a contract that does not require any hassle.
It turns out that technology is the primary productive force.
The two contracts secured 1 billion yuan in funding.
When the representatives of other companies saw this scene, they cursed Zhiren Company and Zhengda Company in their hearts, but they quickened their pace.
In particular, Samsung Group, Taisho Pharmaceutical, and Kobayashi Pharmaceutical deliberately formed a human wall to surround Tian Hemeng in the middle, blocking people from other companies and allowing their own people to talk first.
European and Chinese pharmaceutical companies are relatively calm, or even helpless.
Because importing drugs is not a casual matter. Small countries can open green channels at will, but Europe and China cannot approve it easily.
Pharmaceutical companies also want to make money, but the problem is that it is useless to sign a contract now. If Qingye Medical’s new drug fails to pass local review, they will be embarrassed.
Especially in Europe, it is estimated that Qingye Medical's new drugs will find it difficult to pass review.
Martin from Roche, Karl from Bayer and others all smiled bitterly. After all, they knew too well that given AstraZeneca's nature, there was a high probability that it would secretly block Qingye Medical's new drugs from entering Europe.
When it comes to profit, they will not pay attention to the patients' cries of pain.
Unless Aoba Medical is willing to transfer the drug agency rights to AstraZeneca.
However, since Roche's headquarters is in Switzerland, Martin is confident that he can convince the company's board of directors to allow the new drug to enter Switzerland.
Therefore, pharmaceutical companies from all over the world are now trying their best to persuade local authorities to give Qingye Medical's new drugs a green channel so that they can make money from it.
As for the pharmaceutical companies that are developing vaccines, they are also in a dilemma.
Qingye Medical does not care about the entanglements and various tricks of pharmaceutical companies from various countries.
Anyway, the drugs are in Hongsawadi. As for whether you allow these new drugs to be marketed, that is your own business. Don't even think about asking Qingye Medical to apply and go through the process.
Chia Tai Group, which has already figured out Qingye Medical's temper, plans to quickly promote the launch of Anti-Drug No. 4 - Langfu Anning in Southeast Asia through the Royal Power Group of Siam and several other large business families in Southeast Asian countries.
Sapiens also cooperates with a number of small island nations in the Pacific and Central American countries.
South Korea and Japan, which are severely influenced by the consortium, can also give the green light to new drugs.
An afternoon passed.
Tian Hemeng has signed 13 contracts with a total value of 4.2 billion yuan.
Li Qingye was quite satisfied with the development of Qingye Medical. He did not disturb Tian Hemeng, but took Mao Siqiang, Feili and others and left quietly through a special channel.
However, as soon as he walked out of the door, he met a few Indians who reeked of curry.
"Bana, their company is simply too much. They actually asked us to pay the full amount."
"We are willing to purchase their drugs, but they still ask for a lot more. They are so insincere."
Listening to the curry-flavored English and the arrogance and dissatisfaction in their words, Li Qingye shrugged and got into the SUV.
Mao Siqiang couldn't help laughing, "I'm sorry to make you laugh, but when we do business with Indians, we won't ship unless we get full payment. This is the unspoken rule of the industry."
"I know. Do the Indians have enough gold and silver reserves?"
Mao Siqiang shook his head and said, "Probably not. We imported a batch of generic drugs from Tianzhu some time ago, worth about five million gold yuan, and these guys came directly to pick up the gold and take it back."
"It doesn't matter, they will return the gold." Li Qingye said with a smile.
The situation is just as Li Qingye said. Due to insufficient gold and silver reserves, the wealthy people in India dare not use smuggled drugs casually. When they are forced to do so, they can only fly to Yangon for treatment.
These wealthy people from India exchanged the gold they carried with them for gold dollars at the Qingye Bank in Yangon, and then went to a nearby sanatorium for treatment.
The Indians' idea of draining Hongsawadi of its gold was just a pipe dream.
Especially with the launch of the special medicine Langfu Anning, wealthy Indians who are afraid of death will probably come to Yangon for medical treatment more frequently.
Li Qingye saw the key point clearly, so he did not take the matter of Tianzhu Enterprise's gold exchange seriously.
In order to cash out Hongsavadi's gold on a large scale, there must be a significant trade deficit, but Hongsavadi's gold and yuan trade system is now increasingly tending towards balanced trade.
The so-called balanced trade means that if the other party purchases goods worth 10 billion yuan from us, we will also purchase goods worth 10 billion yuan from the other party, thus achieving the effect of mutual offset.
In this case, the money will return to Aoba Bank after a round trip.
Even if the expenditure occasionally exceeds the limit, the other party will most likely not touch the extra money casually, but will keep it as a reserve.
Moreover, Aoba Bank is not afraid of the other party's exchange. After all, it produces 3 to 5 tons of gold every month. As long as the issuance volume is controlled well, the gold yuan will definitely be extremely strong.
In fact, Hongsavadi now has certain advantages in exports by selling medicines, test strips, rice, timber and agricultural products.
If the import of materials and products is not expanded, Hongsavadi will soon become a net importer of gold.
Li Qingye has already noticed this problem by checking internal intelligence.
In the first half of this year, Hongsavadi saw an inflow of 1,728 kg of gold, while the outflow was only 341 kg.
With the launch of new drugs, it is estimated that there will be another wave of gold inflows.
